United States Prostate Cancer Drugs Market Report 2016

September 2016 | 115 pages | ID: UC8EC9C675EEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Prostate Cancer Drugs

Revenue, means the sales value of Prostate Cancer Drugs

This report studies sales (consumption) of Prostate Cancer Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Abbvie
• Astra Zeneca
• Janssen Pharmaceuticals
• Sanofi
• Amgen
• Astellas Pharma
• Bayer
• BMS
• Dendreon
• Endo Pharmaceuticals
• Ferring Pharmaceutical

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Prostate Cancer Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Prostate Cancer Drugs Market Report 2016

1 PROSTATE CANCER DRUGS OVERVIEW

1.1 Product Overview and Scope of Prostate Cancer Drugs
1.2 Classification of Prostate Cancer Drugs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Prostate Cancer Drugs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Prostate Cancer Drugs (2011-2021)
  1.4.1 United States Prostate Cancer Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES PROSTATE CANCER DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Prostate Cancer Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Prostate Cancer Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Prostate Cancer Drugs Average Price by Manufactures (2015 and 2016)
2.4 Prostate Cancer Drugs Market Competitive Situation and Trends
  2.4.1 Prostate Cancer Drugs Market Concentration Rate
  2.4.2 Prostate Cancer Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES PROSTATE CANCER DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Prostate Cancer Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Prostate Cancer Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Prostate Cancer Drugs Price by Type (2011-2016)
3.4 United States Prostate Cancer Drugs Sales Growth Rate by Type (2011-2016)

4 UNITED STATES PROSTATE CANCER DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Prostate Cancer Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Prostate Cancer Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES PROSTATE CANCER DRUGS MANUFACTURERS PROFILES/ANALYSIS

5.1 Abbvie
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Prostate Cancer Drugs Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Abbvie Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Astra Zeneca
  5.2.2 Prostate Cancer Drugs Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Janssen Pharmaceuticals
  5.3.2 Prostate Cancer Drugs Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Sanofi
  5.4.2 Prostate Cancer Drugs Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Sanofi Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Amgen
  5.5.2 Prostate Cancer Drugs Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Amgen Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Astellas Pharma
  5.6.2 Prostate Cancer Drugs Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Bayer
  5.7.2 Prostate Cancer Drugs Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Bayer Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 BMS
  5.8.2 Prostate Cancer Drugs Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 BMS Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Dendreon
  5.9.2 Prostate Cancer Drugs Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Dendreon Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Endo Pharmaceuticals
  5.10.2 Prostate Cancer Drugs Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Ferring Pharmaceutical

6 PROSTATE CANCER DRUGS MANUFACTURING COST ANALYSIS

6.1 Prostate Cancer Drugs Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Prostate Cancer Drugs

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Prostate Cancer Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES PROSTATE CANCER DRUGS MARKET FORECAST (2016-2021)

10.1 United States Prostate Cancer Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Prostate Cancer Drugs Sales Forecast by Type (2016-2021)
10.3 United States Prostate Cancer Drugs Sales Forecast by Application (2016-2021)
10.4 Prostate Cancer Drugs Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Prostate Cancer Drugs
Table Classification of Prostate Cancer Drugs
Figure United States Sales Market Share of Prostate Cancer Drugs by Type in 2015
Table Application of Prostate Cancer Drugs
Figure United States Sales Market Share of Prostate Cancer Drugs by Application in 2015
Figure United States Prostate Cancer Drugs Sales and Growth Rate (2011-2021)
Figure United States Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)
Table United States Prostate Cancer Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Prostate Cancer Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Prostate Cancer Drugs Sales Share by Manufacturers
Figure 2016 Prostate Cancer Drugs Sales Share by Manufacturers
Table United States Prostate Cancer Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Prostate Cancer Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Prostate Cancer Drugs Revenue Share by Manufacturers
Table 2016 United States Prostate Cancer Drugs Revenue Share by Manufacturers
Table United States Market Prostate Cancer Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Prostate Cancer Drugs Average Price of Key Manufacturers in 2015
Figure Prostate Cancer Drugs Market Share of Top 3 Manufacturers
Figure Prostate Cancer Drugs Market Share of Top 5 Manufacturers
Table United States Prostate Cancer Drugs Sales by Type (2011-2016)
Table United States Prostate Cancer Drugs Sales Share by Type (2011-2016)
Figure United States Prostate Cancer Drugs Sales Market Share by Type in 2015
Table United States Prostate Cancer Drugs Revenue and Market Share by Type (2011-2016)
Table United States Prostate Cancer Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Prostate Cancer Drugs by Type (2011-2016)
Table United States Prostate Cancer Drugs Price by Type (2011-2016)
Figure United States Prostate Cancer Drugs Sales Growth Rate by Type (2011-2016)
Table United States Prostate Cancer Drugs Sales by Application (2011-2016)
Table United States Prostate Cancer Drugs Sales Market Share by Application (2011-2016)
Figure United States Prostate Cancer Drugs Sales Market Share by Application in 2015
Table United States Prostate Cancer Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Prostate Cancer Drugs Sales Growth Rate by Application (2011-2016)
Table Abbvie Basic Information List
Table Abbvie Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbvie Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Astra Zeneca Basic Information List
Table Astra Zeneca Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astra Zeneca Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Janssen Pharmaceuticals Basic Information List
Table Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Pharmaceuticals Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astellas Pharma Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Prostate Cancer Drugs Sales Market Share (2011-2016)
Table BMS Basic Information List
Table BMS Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table BMS Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Dendreon Basic Information List
Table Dendreon Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dendreon Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Endo Pharmaceuticals Basic Information List
Table Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Endo Pharmaceuticals Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Ferring Pharmaceutical Basic Information List
Table Ferring Pharmaceutical Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ferring Pharmaceutical Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer Drugs
Figure Manufacturing Process Analysis of Prostate Cancer Drugs
Figure Prostate Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2015
Table Major Buyers of Prostate Cancer Drugs
Table Distributors/Traders List
Figure United States Prostate Cancer Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Prostate Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Prostate Cancer Drugs Production Forecast by Type (2016-2021)
Table United States Prostate Cancer Drugs Consumption Forecast by Application (2016-2021)